KELLY ENG: Open Payments
NPI 1144974379 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$131 in 5 payments from 5 companies in 2025. Trend: 2023 $302 · 2024 $143 · 2025 $131
Food & beverage: $131
| Company | Payments | Amount |
|---|---|---|
| JAZZ PHARMACEUTICALS INC. | 1 | $31 |
| Daiichi Sankyo Inc. | 1 | $29 |
| Stemline Therapeutics Inc. | 1 | $28 |
| Genentech USA, Inc. | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
Products named: ZEPZELCA, Enhertu, Orserdu, Itovebi, CALQUENCE.
Industry payments across NY — which companies pay providers there.
